Research ArticleClinical Studies
Prognostic Factors for Survival in Patients Treated with Multimodal Therapy for Anaplastic Thyroid Cancer
LUKAS KÄSMANN, LOUISA BOLM, STEFAN JANSSEN and DIRK RADES
Anticancer Research September 2016, 36 (9) 4697-4700;
LUKAS KÄSMANN
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
LOUISA BOLM
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
STEFAN JANSSEN
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
2Medical Practice for Radiotherapy and Radiation Oncology, Hannover, Germany
DIRK RADES
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
In this issue
Anticancer Research
Vol. 36, Issue 9
September 2016
Prognostic Factors for Survival in Patients Treated with Multimodal Therapy for Anaplastic Thyroid Cancer
LUKAS KÄSMANN, LOUISA BOLM, STEFAN JANSSEN, DIRK RADES
Anticancer Research Sep 2016, 36 (9) 4697-4700;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Radiation to the Primary Tumor in Metastatic Anaplastic Thyroid Cancer
- Survival and Surgical Complications in Anaplastic Thyroid Cancer Patients After Completed Multimodal Treatment
- Performance Status and Number of Metastatic Extra-cerebral Sites Predict Survival After Radiotherapy of Brain Metastases from Thyroid Cancer
- Factors Impacting the Overall Survival of Patients Irradiated for Invasive Carcinoma of the Urinary Bladder